Description:
BASAL CELL NEVUS SYNDROME; BCNS
|
Repository
|
NIGMS Human Genetic Cell Repository
|
| Subcollection |
Heritable Diseases |
| Class |
Heritable Cancer Syndromes and other Cancers |
|
Cell Type
|
Fibroblast
|
|
Transformant
|
Untransformed
|
|
Race
|
White
|
|
Family Member
|
1
|
|
Relation to Proband
|
proband
|
|
Confirmation
|
Clinical summary/Case history
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| Passage Frozen |
12 |
| |
| IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase Isoenzyme Electrophoresis |
| |
| Remarks |
See GM01578 Lymph; clinically affected |
| NCBI GTR |
109400 BASAL CELL NEVUS SYNDROME; BCNS |
| OMIM |
109400 BASAL CELL NEVUS SYNDROME; BCNS |
| Omim Description |
BASAL CELL NEVUS SYNDROME; BCNS |
| |
FIFTH PHACOMATOSIS |
| |
GORLIN SYNDROME |
| |
GORLIN-GOLTZ SYNDROMEHYDROCEPHALUS, COSTOVERTEBRAL DYSPLASIA, AND SPRENGEL ANOMALY, INCLUDED |
| |
MULTIPLE BASAL CELL NEVI, ODONTOGENIC KERATOCYSTS, AND SKELETAL ANOMALIES |
| |
NEVOID BASAL CELL CARCINOMA SYNDROME; NBCCS |
| Passage Frozen |
12 |
| Split Ratio |
1:2 |
| Temperature |
37 C |
| Percent CO2 |
5% |
| Percent O2 |
AMBIENT |
| Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
| Serum |
15% fetal bovine serum Not inactivated |
| Substrate |
None specified |
| Subcultivation Method |
trypsin-EDTA |
| Supplement |
- |
|